1260533-36-5CCc1cc(C(N)=O)ccc1-n1nc(C(C)C)c2c(-n3cnc(-c4cnn(C)c4)c3)ccnc21NVVPMZUGELHVMH-UHFFFAOYSA-NTas-116 is pimitespib is a specific inhibitor of heat shock protein 90 (Hsp90) subtypes alpha and beta, with potential antineoplastic and chemo/radiosensitizing activities. Upon oral administration, pimitespib specifically binds to and inhibits the activity of Hsp90 alpha and beta; this results in the proteasomal degradation of oncogenic client proteins, which inhibits client protein dependent-signaling, induces apoptosis, and inhibits the proliferation of cells overexpressing HSP90alpha/beta.
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
BeschreibungTAS-116 (Chinese name: Pimitespib) is an oral heat shock protein 90 (HSP90) α and β subtype selective inhibitor developed by Taiho Pharmaceutical. HSP90 is a molecular chaperone protein that plays a key role in the stability and function of a variety of tumor growth-related proteins. Pimitespib inhibits the activity of HSP90, leading to the degradation of these tumor growth-related proteins, thereby inhibiting the growth and survival of tumor cells.
Wird geladen…
Wird geladen…
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
1260533-36-5DTXSID601358470CHEMBL3661115CHEBI:233475